Frequently Asked Question
On July 23-24, 2026, an FDA advisory committee reviews seven peptides and votes a recommendation on whether licensed pharmacies should be allowed to compound them. That vote is advisory and non-binding - a recommendation, not a final rule. See exactly where each one stands on the tracker.
Get notified
The vote is advisory. The decision that shapes access comes later - if and when the FDA opens a formal public comment window. Most people never hear it opened. Join the list and we'll tell you the instant it does, with step-by-step instructions to file a comment that counts.
